| View |
|
DRP-3601-06
|
Ceftriaxone Sodium
|
Philtrix
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
|
China
|
Renewal
|
24 January 2024
|
14 February 2029
|
| View |
|
DRP-4910-02
|
Vitamin B1 + Vitamin B6 + Vitamin B12
|
Muravit B300
|
300 mg/100 mg/100 mcg
|
Capsule
|
Vitamins
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Renewal
|
22 December 2023
|
13 November 2028
|
| View |
|
DRP-5529-02
|
Tamsulosin Hydrochloride
|
Unbranded
|
200 mcg
|
Enteric-Coated Tablet
|
Alpha-Adrenoreceptor Antagonist
|
Unicure Remedies Pvt. Ltd.
|
India
|
Renewal
|
25 April 2024
|
23 September 2029
|
| View |
|
DRP-6338-01
|
Multivitamins + Iron
|
Muravit Fe Forte
|
(see reverse for formulation)
|
Capsule
|
Vitamins and Mineral
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
21 July 2022
|
28 September 2025
|
| View |
|
DRP-7257-07
|
Vitamin B1 + B6 + B12
|
Muravit B100
|
100 mg/5 mg/50 mcg
|
Tablet
|
Vitamins
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
21 July 2022
|
07 July 2027
|
| View |
|
DRP-7700-01
|
Anastrozole
|
AnnaGet
|
1 mg
|
Film-Coated Tablet
|
Aromatase Inhibitor
|
Hetero Labs Limited (Unit VI, TSIIC, Formulation Sez)
|
India
|
CLIDP Conversion
|
21 July 2022
|
26 August 2026
|
| View |
|
DRP-8426-03
|
Oxaliplatin
|
Oxawind
|
2 mg/mL (100mg/50mL)
|
Solution for Injection (IV Infusion)
|
Antineoplastic
|
ADMAC Lifesciences
|
India
|
Renewal
|
19 May 2023
|
13 September 2028
|
| View |
|
DRP-8699-02
|
Oxaliplatin
|
Oxawind
|
2mg/mL (50mg/25mL)
|
Solution for Injection (IV)
|
Antineoplastic
|
Admac Lifesciences
|
India
|
Renewal
|
31 May 2023
|
12 September 2028
|
| View |
|
DRP-8955-01
|
Ampicillin (as sodium) + Sulbactam (as sodium)
|
Retasul
|
500 mg/ 250 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Penicillin)
|
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
|
China
|
Renewal
|
06 November 2023
|
17 May 2028
|
| View |
|
DRP-10240-01
|
Multivitamins + Dexpanthenol
|
B-REX
|
(see reverse for formulation)
|
Solution for Injection IM/IV
|
Vitamins
|
Kwality Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
21 July 2022
|
21 July 2025
|
| View |
|
DRP-10900-01
|
Levetiracetam
|
Julitam I.V.
|
100mg/ml (500mg/5ml)
|
Concentrated Solution for Injection (IV Infusion)
|
Antiepileptic
|
Aroma Ilac San. Ltd. Sti
|
Turkey
|
CLIDP Conversion
|
21 July 2022
|
14 December 2026
|
| View |
|
DRP-11095-01
|
Sevoflurane
|
Qurvane
|
100% v/v
|
Volatile Liquid for Inhalation
|
General Anesthetic
|
Hana Pharmaceutical Co., Ltd.
|
Korea
|
CLIDP Conversion
|
21 July 2022
|
28 January 2027
|
| View |
|
DRP-11185-01
|
Gefitinib
|
Qualitinib
|
250mg
|
Tablet
|
Antineoplastic
|
Jodas Expoim Pvt. Ltd.
|
India
|
CLIDP Conversion
|
21 July 2022
|
14 February 2027
|
| View |
|
DRP-11230-01
|
Rabeprazole Sodium
|
Reloxa
|
20 mg
|
Lyophilized Powder for Intravenous Injection
|
Proton Pump Inhibitor
|
Gufic Biosciences Ltd.
|
India
|
Renewal
|
28 September 2024
|
10 October 2029
|
| View |
|
DRP-11231-01
|
CHOLECALCIFEROL
|
MEGA D3 1000
|
1000 IU
|
TABLET
|
VITAMIN
|
DELTA PHARMA LTD.
|
Bangladesh
|
CLIDP Conversion
|
21 July 2022
|
11 August 2026
|
| View |
|
DRP-11250-02
|
Cefuroxime (as sodium)
|
Newxime
|
750 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Swiss Parenterals Ltd
|
India
|
CLIDP Conversion
|
21 July 2022
|
17 February 2027
|
| View |
|
DRP-11354-01
|
Ezetimibe
|
EzeGet
|
10 mg
|
Tablet
|
Lipid Modifying Agent (Cholesterol Absorption Inhibitor)
|
Hetero Labs Limited
|
India
|
CLIDP Conversion
|
21 July 2022
|
03 March 2027
|
| View |
|
DRP-11720-01
|
Moxifloxacin (as hydrochloride)
|
Moxidin
|
5mg/mL (0.5% w/v)
|
Ophthalmic Solution
|
Antiinfective (Fluoroquinolone)
|
Hanlim Pharm. Co., Ltd.
|
Korea
|
CLIDP Conversion
|
21 July 2022
|
22 April 2027
|
| View |
|
DRP-11747-01
|
Capecitabine
|
CapeGet
|
500 mg
|
Film-Coated Tablet
|
Antineoplastic Agent (Pyrimidine Analogue)
|
Hetero Labs Limited (Unit VI)
|
India
|
CLIDP Conversion
|
21 July 2022
|
12 January 2027
|
| View |
|
DPR-2361-01
|
ESOMEPRAZOLE (AS SODIUM)
|
VEGRON
|
40MG
|
POWDER FOR INJECTION (IV)
|
PROTON PUMP INHIBITOR
|
Lyka Labs Limited
|
India
|
Renewal
|
18 July 2022
|
05 August 2027
|